Agenda
14h00 - 14h10 Opening remarks
Speaker: Olinda Marques (Endocrinology, Braga Local Health Unit)
14h10 – 14h30 Year in review on Neuroendocrine Tumors: what’s new?
Speaker: Diana Duarte (Endocrinology, Braga Local Health Unit)
Moderator: Joana Saraiva (Endocrinology, Coimbra Local Health Unit)
14h30 – 15h10
1st table: Approach to genetic syndromes predisposing to Neuroendocrine tumours: Screening and follow-up of (a)symptomatic carriers
Speaker: Raquel Martins (Endocrinology, Coimbra Portuguese Oncology Institute)
Moderators: Ana Paula Marques (Endocrinology, Matosinhos Local Health Unit), Branca M. Cavaco (Investigator, Lisbon Portuguese Oncology Institute)
15h10 – 15h50
2nd table: Functioning gastroenteropancreatic neuroendocrine tumours: Clinical presentation, diagnosis and management of hormonal syndromes
Speaker: Joana Maciel (Endocrinology, Braga Local Health Unit)
Moderators: Maria João Bugalho (Endocrinology), Ana Paula Santos (Endocrinology, Oporto Portuguese Oncology Institute)
15h50 – 16h05 Short Oral
Moderator: Gustavo Rocha (Endocrinology, Gaia Espinho Local Health Unit)
Difficulties in the management of hypoglycemia in a patient with metastatic insulinoma: Juliana Marques-Sá (Endocrinology, Braga Local Health Unit)
Composite Duodenal Gangliocytoma/Neuroma and Neuroendocrine Tumor (CogNET): A rare Case Report: Ariana Maia (ULS Santo António)
16h05 – 16h15 Short Break
16h15 – 17h35
3rd table: Treatment options for advanced disease
16h15 – 16h35
Systemic medical treatment: Elisabete Couto (Oncology, Braga Local Health Unit)
16h35 – 16h55
Hepatic arterial radioembolization: Liliana Violante (Nuclear Medicine, Oporto Portuguese Oncology Institute)
16h55 – 17h15
PRRT: Laura Evangelista (Nuclear Medicine, Humanitas University, Padua, Italy)
17h15 – 17h35 Discussion
Moderators: Maria Joana Santos (Endocrinology, Braga Local Health Unit), Gracinda Costa (Medicina Nuclear, Coimbra Local Health Unit)
17h35 – 17h50 Short Oral
Moderator: Cláudia Amaral (Endocrinology, Santo António Local Health Unit)
From First-Line to Peptide Receptor Radionuclide Therapy: A Comprehensive Case Study of Advanced Pancreatic Neuroendocrine Tumor: Joana Gonçalves (ULS Arco Ribeirinho. Hospital Nossa Senhora do Rosário, Barreiro)
Pancreatic neuroendocrine tumour in the context of MEN1 diagnosis: Valentim Lopes (Endocrinology, Braga Local Health Unit)
17h50 – 18h00 Closing remarks
Organization: Endocrinology Department, Braga Local Health Unit, Portugal | Associação dos Amigos de Endoc